By contrast, in HBV-HCC, the TT genotype of visfatin rs61330082 was associated with a higher risk of HBV-HCC than the CC and CC + TT genotypes, but only in patients of Zhuang but not Han ethnicity [24]. Here, NAMPT is linked to hepatocellular carcinoma.